A study of symptomatic R6/1 animals demonstrated that they had increased levels of inhibitory phosphorylation of GSK3β, suggesting the decreased activity of this molecule in the HD R6/1 model (Lim et al., 2014). This evidence concerns the gene GSK3B and Huntington disease.